Magni Jonsson
- Impact of reimbursement changes for fixed ICS/LABA combination treatment in IcelandBy Unnur Bjornsdottir, Jon Steinar Jonsson, Magni Jonsson, Sigurveig Thora Sigurdardottir, Georgios Stratelis, Gunilla Telg, Marcus Turesson and Sveinbjorn GizurarsonUnnur Bjornsdottir1Department of Allergy and Clinical Immunology, Faculty of Medicine, University of Iceland, Reykjavik, IcelandJon Steinar Jonsson2General Practice, Gardabaer Health Center, Gardabaer, IcelandMagni Jonsson3Department of Respiratory Medicine, Allergy and Sleep, Landspitali University Hospital, Reykjavik, IcelandSigurveig Thora Sigurdardottir4Department of Immunology, Landspitali University Hospital, Reykjavik, IcelandGeorgios Stratelis5Medical, AstraZeneca Nordic, Södertälje, SwedenGunilla Telg6Medical, AstraZeneca Nordic, Södertälje, SwedenMarcus Turesson7Medical, Statisticon, Stockholm, SwedenSveinbjorn Gizurarson8Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.